热搜第一！股价大跌，霸王茶姬回应“咖啡因”

Core Viewpoint - The article discusses the recent controversy surrounding Bawang Chaji due to caffeine content in its beverages, which has led to a significant drop in the company's stock price, reaching an all-time low since its IPO [1][7]. Group 1: Caffeine Controversy - Bawang Chaji has faced criticism regarding the caffeine levels in its drinks, with some consumers reporting negative effects such as insomnia and palpitations after consumption [2][10]. - The topic of "Bawang Chaji caffeine" gained traction on social media, leading to widespread discussion and concern among consumers [2][4]. Group 2: Stock Performance - Following the controversy, Bawang Chaji's stock price fell sharply, with a pre-market drop of 10% and an intraday decline of nearly 16%, closing at $11.90 per share, which is over 64% lower than its price on the first day of trading in April [7][8]. Group 3: Company Response - In response to the allegations, Bawang Chaji stated that it is aware of the rumors and misinformation circulating about the company and is committed to protecting its rights legally [4][10]. - The company emphasized that the caffeine content in its tea drinks is comparable to that of a latte and significantly lower than that of an Americano, highlighting its commitment to using whole leaf tea rather than lower-quality ingredients [10][11]. - Bawang Chaji has introduced a product called "Light Caffeine · Boya Juexian," which reduces caffeine content by approximately 50%, and is exploring the possibility of creating caffeine-free tea options for sensitive consumers [10][13].